Trends in Launch Prices and Price Increases for New Medicines for Urological Cancers

J Urol. 2022 Sep;208(3):514-516. doi: 10.1097/JU.0000000000002825. Epub 2022 Jun 27.
No abstract available

Keywords: Medicare Part D; drug costs; health policy; reimbursement, incentive; urologic neoplasms.

Publication types

  • Editorial

MeSH terms

  • Humans
  • Urologic Neoplasms* / drug therapy